Fujian South Pharmaceutical Co., Ltd. is a leading manufacturer in the pharmaceutical industry, specialising in the production of Active Pharmaceutical Ingredients (APIs). Established in 2001 and located in Mingxi County, Fujian Province, China, FSP has emerged as a prominent cGMP manufacturer for oncology APIs. The company is recognised globally as a key supplier of natural and semi-synthetic Paclitaxel, Docetaxel, and other essential oncology compounds, leveraging its extensive cultivation of Taxus Wallichiana across 7,000 acres.

Services include:
- APIs (Active Pharmaceutical Ingredients)
- Natural Paclitaxel
- Semi-synthetic Paclitaxel
- Docetaxel
- 10-DAB III (from Taxus Baccata and Taxus Wallichiana)
- Gemcitabine
- Irinotecan
- Patented technologies for Docetaxel, Imatinib, and Erlotinib

Fujian South Pharmaceutical Co., Ltd. continues to play a vital role in the pharmaceutical supply chain, providing high-quality products to meet the demands of the industry. For more information, please visit southpharma.com.